Karin Enell Smith

Title: Karin Enell Smith: Innovator in Antibody Research

Introduction

Karin Enell Smith is a prominent inventor based in Lund, Sweden. She has made significant contributions to the field of biotechnology, particularly in the development of antibodies for therapeutic applications. With a total of 3 patents, her work focuses on innovative solutions for treating diseases such as cancer.

Latest Patents

Karin's latest patents include groundbreaking inventions related to Anti-CD137 antibodies. These antibodies, along with their fragments, variants, fusions, and derivatives, exhibit binding specificity for domain 2 of human CD137. They are capable of inhibiting the binding of a reference antibody to human CD137. The utility of these antibodies extends to the treatment of various diseases, particularly cancer. Additionally, her inventions encompass pharmaceutical compositions, methods, and kits that incorporate these antibodies.

Career Highlights

Karin Enell Smith is currently associated with Alligator Bioscience AB, a company dedicated to advancing antibody-based therapies. Her role in this organization highlights her commitment to innovative research and development in the field of biotechnology.

Collaborations

Throughout her career, Karin has collaborated with notable colleagues, including Peter Ellmark and Niina Veitonmaki. These partnerships have contributed to her success and the advancement of her research.

Conclusion

Karin Enell Smith stands out as a leading inventor in the field of antibody research, with a focus on developing innovative treatments for cancer. Her contributions through her patents and collaborations continue to impact the biotechnology landscape significantly.